Average obligated amount per year since period start.
Portion of total contract value already obligated.
Share of total value represented by subawards.
DRUG PRODUCT FORMULATION DEVELOPMENT, GMP MANUFACTURE, AND LONG-TERM STABILITY STUDIES OF BITOX FOR PHASE I CLINICAL TRIALS
Task order obligations
Estimated months remaining until end of performance.
Period of performance
91% of period elapsed
Awarding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Funding Agency
NINATIONAL INSTITUTES OF HEALTH
Code: 7529
Loading contract activity data...
Modification ID | Description | Action Date | Obligated Amount | Action Type |
|---|---|---|---|---|
Subaward # | Subawardee | Description | Amount | Action Date |
|---|---|---|---|---|